ION PACIFIC, INC.
ION PACIFIC, INC. is a Series B and Series C+ fund in the US, Europe, Israel and Southeast Asia writing $2M–$25M checks into Enterprise, Fintech, Healthcare, healthcare-tech, aerospace, defense, specialized-finance, enterprise-applications and high-tech.
- Stages
- Series B, Series C+
- Sectors
- Enterprise, Fintech, Healthcare, healthcare-tech, aerospace, defense, specialized-finance, enterprise-applications, high-tech
- Check size
- $2M–$25M
- Invests in
- US-wide, Europe, Israel, Southeast Asia
- Actively investing
- Yes
- Founded
- 2015
- Assets under management
- $195M
- Website
- ionpacific.com
Thesis
ION PACIFIC, INC. is a global investment firm specializing in structured investments in secondary opportunities within the venture-stage technology sector. The firm focuses on healthcare, biotech, fintech, aerospace, defense, financial services, specialized finance, business productivity software, enterprise applications, and high tech. They invest in venture-stage companies, typically Series B and later, across North America, Europe, Israel, and Southeast Asia. Ion Pacific employs a structured secondaries approach, combining downside protection with uncapped upside return potential. They target general partners (GPs), limited partners (LPs), and founders, helping them meet liquidity needs while providing investors with opportunities for future asset appreciation. They manage multiple funds, including Stonecutter, Pathway, and Southeast Asia Opportunities. Stonecutter III closed on 195000000 USD. Ion Pacific Stonecutter II closed at 133600000 USD.
Common questions
Does ION PACIFIC, INC. invest at the Series B stage?
Yes. ION PACIFIC, INC. lists Series B and Series C+ among the stages it invests in.
What check size does ION PACIFIC, INC. write?
ION PACIFIC, INC. writes $2M–$25M checks.
Where does ION PACIFIC, INC. invest?
ION PACIFIC, INC. invests in the US, Europe, Israel and Southeast Asia.